Alphatec Holdings director Demski buys $408,600 of common stock

David M. Demski, a director at Alphatec Holdings Inc. (NASDAQ:ATEC), recently increased his stake in the company by purchasing 60,000 shares of Alphatec Holdings common stock. This acquisition amounted to a total of $408,600, executed on October 30, 2026, at a price of $6.81 per share—the lowest point of the stock's 52-week trading range. The move appears to be part of a pre-planned strategy, as Demski had established a Rule 10b5-1 trading plan on June 15, 2026.

As of the purchase, Demski now directly owns 491,635 shares of Alphatec Holdings common stock. The stock has faced a steep decline of 64% year-to-date, but InvestorsPro analysts suggest that the company's net income is anticipated to increase this year. For those interested in a comprehensive analysis of ATEC's valuation and growth potential, the Pro Research Report is available for this and over 1,400 other US equities.

In related news, Alphatec Holdings reported third-quarter earnings for 2026 that fell short of Wall Street expectations. The company reported adjusted earnings of $0.09 per share, falling below the estimated $0.10, and revenue of $221.17 million, which was lower than the expected $225.44 million. Despite a 13% year-over-year revenue increase, the company encountered challenges with biologics sales, leading to a reduction in its full-year financial outlook.

In reaction to these events, TD Cowen lowered its price target for Alphatec to $10 from $13, while Needham adjusted its target to $12 from $14, maintaining a Buy rating but citing the revenue miss and revised guidance as the reasons for the downgrade. These developments have prompted a reassessment of analysts' expectations for Alphatec, focusing on its financial performance and market conditions.